Role of fetal head-circumference-to-maternal-height ratio in predicting Cesarean section for labor dystocia: prospective multicenter study.


Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
01 2023
Historique:
revised: 01 06 2022
received: 29 03 2022
accepted: 16 06 2022
pubmed: 30 6 2022
medline: 6 1 2023
entrez: 29 6 2022
Statut: ppublish

Résumé

To evaluate the relationship between the fetal head-circumference-to-maternal-height (HC/MH) ratio measured shortly before delivery and the occurrence of Cesarean section (CS) for labor dystocia. This was a multicenter prospective cohort study involving four tertiary maternity hospitals. An unselected cohort of women with a singleton fetus in cephalic presentation, at a gestational age beyond 36 + 0 weeks and without any contraindication for vaginal delivery, was enrolled between September 2020 and November 2021. The MH and fetal HC were measured on admission of the patient to the labor ward. The primary outcome of the study was the performance of the HC/MH ratio in the prediction of CS for labor dystocia. Women who underwent CS for any indication other than failed labor progression, including fetal distress, were excluded from the final analysis. A total of 783 women were included in the study. Vaginal delivery occurred in 744 (95.0%) women and CS for labor dystocia in 39 (5.0%). CS for labor dystocia was associated with shorter MH (mean ± SD, 160.4 ± 6.6 vs 164.5 ± 6.3 cm; P < 0.001), larger fetal HC (339.6 ± 9.5 vs 330.7 ± 13.0 mm; P < 0.001) and a higher HC/MH ratio (2.12 ± 0.11 vs 2.01 ± 0.10; P < 0.001) compared with vaginal delivery. Multivariate logistic regression analysis showed that the HC/MH ratio was associated independently with CS for labor dystocia (adjusted odds ratio, 2.65 (95% CI, 1.85-3.79); P < 0.001). The HC/MH ratio had an area under the receiver-operating-characteristics curve of 0.77 and an optimal cut-off value for discriminating between vaginal delivery and CS for labor dystocia of 2.09, which was associated with a sensitivity of 0.62 (95% CI, 0.45-0.77), specificity of 0.79 (95% CI, 0.76-0.82), positive predictive value of 0.13 (95% CI, 0.09-0.19) and negative predictive value of 0.98 (95% CI, 0.96-0.99). In a large cohort of unselected pregnancies, the HC/MH ratio performed better than did fetal HC and MH alone in identifying those cases that will undergo CS for labor dystocia, albeit with moderate predictive value. The HC/MH ratio could assist in the evaluation of women at risk for CS for labor dystocia. © 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Identifiants

pubmed: 35767709
doi: 10.1002/uog.24981
pmc: PMC10107777
doi:

Types de publication

Multicenter Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

93-98

Informations de copyright

© 2022 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.

Références

Lancet. 2015 Jun 27;385(9987):2600-5
pubmed: 25863654
Int J Equity Health. 2020 Jul 31;19(1):95
pubmed: 32731894
Trop Doct. 1997 Jul;27(3):129-30
pubmed: 9227001
Am J Obstet Gynecol. 2021 Aug;225(2):171.e1-171.e12
pubmed: 33675795
Ultraschall Med. 2017 Oct;38(5):558-559
pubmed: 28683513
Am J Obstet Gynecol. 2020 Sep;223(3):445.e1-445.e15
pubmed: 32883453
Ultrasound Obstet Gynecol. 2017 Jun;49(6):803-804
pubmed: 27619356
Ultrasound Obstet Gynecol. 2015 Feb;45(2):229-31
pubmed: 24753011
Acta Obstet Gynecol Scand. 2017 Aug;96(8):1006-1011
pubmed: 28449356
BJOG. 2005 Nov;112(11):1461-6
pubmed: 16225563
Ultrasound Obstet Gynecol. 2013 Feb;41(2):198-203
pubmed: 22605519
Chin Med J (Engl). 2021 Apr 20;134(9):1070-1078
pubmed: 33883411
Am J Obstet Gynecol. 2003 May;188(5):1372-8
pubmed: 12748514
Eur J Obstet Gynecol Reprod Biol. 2020 Sep;252:62-69
pubmed: 32570187
Am J Obstet Gynecol. 2015 Dec;213(6):833.e1-833.e12
pubmed: 26254515
BJOG. 2016 Jan;123(1):77-88
pubmed: 26224221
Iran J Radiol. 2013 Sep;10(3):185-7
pubmed: 24348610
Colomb Med (Cali). 2013 Sep 30;44(3):146-54
pubmed: 24892612
PLoS One. 2018 May 29;13(5):e0198124
pubmed: 29813118
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Acta Obstet Gynecol Scand. 2021 Oct;100(10):1917-1923
pubmed: 34240404
Int J Gynaecol Obstet. 2009 Oct;107(1):62-3
pubmed: 19577235
Gynecol Obstet Invest. 2000;49(3):160-4
pubmed: 10729755
J Obstet Gynaecol Res. 2011 Dec;37(12):1868-71
pubmed: 21955210
Obstet Gynecol. 2011 Jul;118(1):29-38
pubmed: 21646928
J Obstet Gynaecol Can. 2012 Aug;34(8):721-746
pubmed: 22947405
Arch Gynecol Obstet. 2017 Feb;295(2):351-359
pubmed: 28044181
Int J Gynaecol Obstet. 2015 Apr;129(1):22-5
pubmed: 25575424
Eur J Obstet Gynecol Reprod Biol. 2019 Dec;243:26-31
pubmed: 31670065
Fetal Diagn Ther. 2016;40(2):150-5
pubmed: 26555940
Am J Obstet Gynecol. 1992 Jul;167(1):7-11
pubmed: 1442959
Arch Gynecol Obstet. 2018 Aug;298(2):433-441
pubmed: 29948169
Int Surg. 1982 Jan-Mar;67(1):57-62
pubmed: 7096006
Int J Gynaecol Obstet. 1989 Mar;28(3):243-51
pubmed: 2564354
Ultrasound Obstet Gynecol. 2009 Nov;34(5):566-71
pubmed: 19582801
Am J Obstet Gynecol. 2018 Mar;218(3):339.e1-339.e7
pubmed: 29305249
Fetal Diagn Ther. 2017;42(4):249-256
pubmed: 28399531
BMC Pregnancy Childbirth. 2013 May 07;13:106
pubmed: 23651454
Am J Obstet Gynecol. 2014 Mar;210(3):179-93
pubmed: 24565430
PLoS One. 2018 Feb 6;13(2):e0192167
pubmed: 29408912
Obstet Gynecol. 1990 Aug;76(2):159-63
pubmed: 2371019
Ultrasound Obstet Gynecol. 2015 Nov;46(5):606-10
pubmed: 25536955
Ultrasound Obstet Gynecol. 2012 Jul;40(1):117-8
pubmed: 22223511
Aust N Z J Obstet Gynaecol. 2016 Dec;56(6):571-577
pubmed: 27628240
Ultrasound Obstet Gynecol. 2019 Jun;53(6):715-723
pubmed: 31169958
J Nutr. 2015 Nov;145(11):2542-50
pubmed: 26423738
Trop Med Int Health. 1996 Aug;1(4):510-21
pubmed: 8765460
Midwifery. 1992 Mar;8(1):3-7
pubmed: 1598090
Ultrasound Obstet Gynecol. 2012 Feb;39(2):238-40
pubmed: 21523842
Obes Rev. 2009 Jan;10(1):28-35
pubmed: 19021871
Acta Obstet Gynecol Scand. 2012 Apr;91(4):470-5
pubmed: 22229662

Auteurs

A Dall'Asta (A)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.

R Ramirez Zegarra (R)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.
Department of Obstetrics and Gynecology, St Joseph Krankenhaus, Berlin, Germany.

E Corno (E)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.

I Mappa (I)

Department of Obstetrics and Gynecology, Fondazione Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.

J L A Lu (JLA)

Department of Obstetrics and Gynecology, Fondazione Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.

E Di Pasquo (E)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.

G Morganelli (G)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.

M Abou-Dakn (M)

Department of Obstetrics and Gynecology, St Joseph Krankenhaus, Berlin, Germany.

C Germano (C)

Department of Obstetrics and Gynecology, Sant'Anna Hospital, University of Turin, Turin, Italy.

R Attini (R)

Department of Obstetrics and Gynecology, Sant'Anna Hospital, University of Turin, Turin, Italy.

B Masturzo (B)

Department of Obstetrics and Gynecology, Sant'Anna Hospital, University of Turin, Turin, Italy.

G Rizzo (G)

Department of Obstetrics and Gynecology, Fondazione Policlinico Tor Vergata, University of Rome Tor Vergata, Rome, Italy.

T Ghi (T)

Department of Medicine and Surgery, Obstetrics and Gynecology Unit, University of Parma, Parma, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH